HDL- C (съответно - 43, 0%, - 28, 0%, - 24, 9%) и значително повишава HDL- C (съответно 27, 5%, 6, 0%, 23, 4%).
Sammenlignet med simvastatin alene eller Trevaclyn (2. 000 mg/ 40 mg) alene i 12 uger sænkede Trevaclyn (2. 000 mg/ 40 mg) sammen med simvastatin LDL- C (henholdsvis - 47, 9%, - 37, 0%, - 17, 0%), TG (henholdsvis - 33, 3%, - 14, 7%, - 21, 6%), apo B (henholdsvis - 41, 0%, - 28, 8%, - 17, 1%) og TC (henholdsvis - 29, 6%, - 24, 9%, 9, 1%) samt LDL- C: HDL- C (henholdsvis - 57, 1%, - 39, 8%, - 31, 2%), non- HDL- C (henholdsvis - 45, 8%, - 33, 4%, - 18, 1%) og TC: HDL- C (henholdsvis - 43, 0%, - 28, 0%, - 24, 9%) signifikant og øgede HDL - C signifikant (henholdsvis 27, 5%, 6, 0%, 23, 4%).